KathleenMullaneDOPharm. D.

PubMed

• MSG-15: Super-Bioavailability Itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses-A Multicenter, Open-Label, Randomized Comparative Trial.
  Andrej Spec, George R Thompson, Marisa H Miceli, Justin Hayes, Laurie Proia, David McKinsey, Ana Belen Arauz, Kathleen Mullane, Jo-Ann Young, Gerald McGwin, Rachel McM...> ;Open Forum Infectious Diseases. 2024 Mar 1
• 9 citations
  American Society for Transplantation and Cellular Therapy Series: #5-Management of Clostridioides difficile Infection in Hematopoietic Cell Transplant Recipients.
  Carolyn D Alonso, Gabriela Maron, Mini Kamboj, Paul A Carpenter, Arun Gurunathan, Kathleen M Mullane, Erik R Dubberke> ;Transplantation and Cellular Therapy. 2022 May 1
• 9 citations
  Misdiagnosis of Bordetella bronchiseptica Respiratory Infection as Bordetella pertussis by Multiplex Molecular Assay.
  Moira McNulty, Dena R. Shibib, Jennifer L. Steinbeck, Kathleen M. Mullane, Jennifer Pisano, Scott Matushek, Kathleen G. Beavis, Vera Tesic, David Pitrak> ;Clinical Infectious Diseases. 2018 Nov 28
• 11 citations
  Erratum: Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease ...
  Oliver A. Cornely, Michael N. Robertson, Shariq Haider, Andrew Grigg, Michelle Geddes, Mickael Aoun, Werner J. Heinz, Issam I Raad, Urs Schanz, Ralf G. Meyer, Sarah P....> ;The Journal of Antimicrobial Chemotherapy. 2017 Dec 1
• 11 citations
  Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.
  Oliver A Cornely, Michael N Robertson, Shariq Haider, Andrew Grigg, Michelle Geddes, Mickael Aoun, Werner J Heinz, Issam Raad, Urs Schanz, Ralf G Meyer, Sarah P Hammon...> ;The Journal of Antimicrobial Chemotherapy. 2017 Dec 1
• 242 citations
  Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation
  Roy F. Chemaly, Andrew J. Ullmann, Susanne Stoelben, Marie Paule Richard, Martin Bornhäuser, Christoph Groth, Hermann Einsele, Margarida Silverman, Kathleen M. Mullane...> ;The New England Journal of Medicine. 2014 May 7
• 98 citations
  Reduced Acquisition and Overgrowth of Vancomycin-Resistant Enterococci and Candida Species in Patients Treated With Fidaxomicin Versus Vancomycin for Clostridium diffi...
  Michelle M. Nerandzic, Kathleen M. Mullane, Mark A. Miller, Farah Babakhani, Curtis J. Donskey> ;Clinical Infectious Diseases. 2012 Aug 1
• A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidi...
  Betts RF, Nucci M, Talwar D, Gareca M, Queiroz-Telles F, Bedimo RJ, Herbrecht R, Ruiz-Palacios G, Young JA, Baddley JW, Strohmaier KM, Tucker KA, Taylor AF, Kartsonis ...> ;Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
• High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients.
  Saag M, Balu R, Phillips E, Brachman P, Martorell C, Burman W, Stancil B, Mosteller M, Brothers C, Wannamaker P, Hughes A, Sutherland-Phillips D, Mallal S, Shaefer M, ...> ;Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
• 38 citations
  A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in He...
  Francisco M. Marty, Roy F. Chemaly, Kathleen M. Mullane, Dong-Gun Lee, Hans H. Hirsch, Catherine B. Small, Anne Bergeron, Shmuel Shoham, Per Ljungman, Alpana Waghmare,...> ;Clinical Infectious Diseases. 2020 Dec 31
• 46 citations
  A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hemat...
  Roy F. Chemaly, Sanjeet Dadwal, Anne Bergeron, Per Ljungman, Yae Jean Kim, Guang-Shing Cheng, Sudhakar Pipavath, Ajit P. Limaye, Elodie Blanchard, Drew J. Winston, Pat...> ;Clinical Infectious Diseases. 2020 Dec 31
• 42 citations
  Remdesivir Use in the Setting of Severe Renal Impairment: A Theoretical Concern or Real Risk?
  Natasha N Pettit, Jennifer Pisano, Cynthia T Nguyen, Alison K Lew, Aniruddha Hazra, Renslow Sherer, Kathleen M. Mullane> ;Clinical Infectious Diseases. 2020 Dec 14
• 22 citations
  Distinctive gene and protein characteristics of extremely piezophilic Colwellia.
  Logan M. Peoples, Than S. Kyaw, Juan A. Ugalde, K.K. Mullane, Roger A. Chastain, A. Aristides Yayanos, Masataka Kusube, Barbara Methé, Douglas H. Bartlett> ;BMC Genomics. 2020 Oct 6
• 1 citations
  Cording in Disseminated Mycobacterium chelonae Infection in an Immunocompromised Patient
  Gregory Olson, Moira McNulty, Kathleen M. Mullane, Kathleen G. Beavis, Vera Tesic> ;Laboratory Medicine. 2021 May 4
• 10 citations
  Changes in Intravenous Immunoglobulin Usage for Hypogammaglobulinemia After Implementation of a Stewardship Program.
  Benjamin A. Derman, Zachary Schlei, Sandeep Parsad, Kathleen M. Mullane, Randall W. Knoebel> ;JCO Oncology Practice. 2021 Mar 1
• 820 citations
  Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
  Christoph D. Spinner, Robert L. Gottlieb, Gerard J. Criner, José Ramón Arribas López, Anna Maria Cattelan, Alex Soriano Viladomiu, Onyema Ogbuagu, Prashant Malhotra, K...> ;JAMA. 2020 Sep 15
• 5 citations
  Immunogenicity of Inactivated Varicella Zoster Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients and Patients With Solid or Hematologic Cancer.
  Michael Boeckh, Ann M. Arvin, Kathleen M. Mullane, Luis H. Camacho, Drew J. Winston, Vicki A. Morrison, Kimberly Hurtado, Jessie Durrand Hall, Lei Pang, Shu-Chih Su, S...> ;Open Forum Infectious Diseases. 2020 Jun 2
• 888 citations
  Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
  Jason D Goldman, David C. Lye, David S.C. Hui, Kristen M. Marks, Raffaele Bruno, Rocio Montejano, Christoph D. Spinner, Massimo Galli, Mi Young Ahn, Ronald Nahass, Yao...> ;The New England Journal of Medicine. 2020 May 27
• 7 citations
  Exploratory evaluation of bezlotoxumab on outcomes associated with Clostridioides difficile infection in MODIFY I/II participants with cancer
  Oliver A. Cornely, Kathleen M. Mullane, Thomas Birch, Sabine Hazan-Steinberg, Richard Nathan, Emilio Bouza, David P. Calfee, Misoo C. Ellison, Michael T Wong, Mary Bet...> ;Open Forum Infectious Diseases. 2020 Jan 31
• Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.
  Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim YS, Yoshida J, Gabryelski L, Pedley A, Eves ...> ;The New England journal of medicine.
• 31 citations
  Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplanta...
  Kathleen M. Mullane, Erik R. Dubberke> ;Clinical Transplantation. 2019 Sep 1
• 108 citations
  Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc e...
  Alemnew F Dagnew, Osman Ilhan, Won Sik Lee, Dariusz Woszczyk, Jae Yong Kwak, Stella Bowcock, Sang Kyun Sohn, Gabriela Rodriguez Macías, Tzeon Jye Chiou, Dimas Quiel, M...> ;The Lancet. Infectious Diseases. 2019 Aug 6
• 21 citations
  Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial
  Kathleen M. Mullane, Vicki A. Morrison, Luis H. Camacho, Ann M. Arvin, Shelly A. McNeil, Jessie Durrand, Bernadette Campbell, Shu-Chih Su, Ivan S. F. Chan, Janie Parri...> ;The Lancet. Infectious Diseases. 2019 Aug 6
• MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis.
  Spec A, Pullman J, Thompson GR, Powderly WG, Tobin EH, Vazquez J, Wring SA, Angulo D, Helou S, Pappas PG, Mycoses Study Group> ;The Journal of antimicrobial chemotherapy. 2019-07-15
• 113 citations
  Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials.
  Roy F. Chemaly, Sunwen Chou, Hermann Einsele, Paul D. Griffiths, Robin K. Avery, Raymund R. Razonable, Kathleen M. Mullane, Camille N. Kotton, Jens D Lundgren, Takashi...> ;Clinical Infectious Diseases. 2019 Apr 8
• Join now to see all

Journal Articles

• Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19  
  Robert L Gottlieb, Gerard J Criner, Onyema Ogbuagu, Kathleen M Mullane, Anuj Gaggar, Diana M Brainard, Gregory Huhn, JAMA
• Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials  
  Roy F Chemaly, Kathleen M Mullane, Robin Avery, Raymund R Razonable, Clinical Infectious Diseases
• Misdiagnosis of Bordetella Bronchiseptica Respiratory Infection as Bordetella Pertussis by Multiplex Molecular Assay  
  Vera Tesic, Kathleen Mullane, Kathleen G Beavis, Jennifer Pisano, Moira C McNulty, Jennifer L Steinbeck, David Pitrak, Clinical Infectious Diseases

Lectures

• New Insights into the Diagnosis and Treatment of CDI. 
  Park Ridge, IL - 9/17/2013
• New Treatments in the Management of CDI. 
  Lansing, MI - 8/7/2013
• C-Diff Infection: Changing Trends & New Treatments for the Enemy Within. 
  Englewood, CO - 4/27/2013
• The Epidemiologic and Economic Burden of CDI and Treatment Strategies. 
  St. Louis, MO - 2/26/2013
• Management of CDI Infection. 
  Oak Lawn, IL - 1/3/2013
• Clostridium difficile in High Risk Individuals. 
  Urbana, IL - 9/27/2012
• Fidaxomicin and Other Macrocyclic Antibiotics. 
  San Francisco, CA - 9/1/2012
• Risk Factors for CDI in Immunocompromised Hosts. 
  Kansas City, KS - 8/2/2012
• Evolving Treatments for Clostridium. 
  Springfield, IL - 3/22/2012
• Emerging CDI Treatment Options. 
  University of Chicago - 3/12/2012
• Effect of Immune Dysfunction and Diminished Renal Function on CDI outcomes. 
  University of Chicago - 3/9/2012
• Effect of Immune Dysfunction and Diminished Renal Function on CDI Treatment Outcomes. 
  3/9/2012
• New Treatments in the Management of Clostridium difficile Infection. 
  Detroit, MI - 1/8/2012
• Appropriate use of Antifungal Agents; Is this an oxymoron? 
  Maywood, IL - 12/14/2011
• Diagnosis and Management of CDI. 
  Chicago, IL - 10/31/2011
• Reducing the Burden of CDI: From Initial Treatment to Recurrence Prevention. 
  Ann Arbor, MI - 10/12/2011
• New Treatments in the Management of Clostridium difficile Infection. 
  Alpena, MI - 10/11/2011
• New Treatments for CDI. 
  Chicago, IL - 10/4/2011
• Clostridium Difficile: Risks for Infection and Recurrent Disease. 
  Boston, MA - 10/1/2011
• Clostridium Difficile: Pathophysiology, Risk Factors, and Recurrence. 
  Chicago, IL - 9/17/2011
• Updated IDSA Guidelines for the Treatment of Candidemia. 
  Columbia, SC - 2/8/2011
• Pharmacology and Therapeutics: Antimycotic agents. 
  7/19/2010
• Candidemia. 
  University of Chicago - 10/17/2008
• Antifungal Update. 
  University of Chicago - 8/29/2008
• Infections in Solid Organ Transplantation. 
  University of Illinois, Chicago, IL - 5/23/2008
• Join now to see all

Other

• Prevention, Diagnosis and Management of Opportunistic Infections in Individuals Living with Chronic Graft versus Host Disease. 
  Mullane KM, Living with Chronic GVHD; An Educational Symposium for Patients, Families and Healthcare Professiona
  http://bmtinfonet.org/
  10/30/2010
• The 2007 Process of Care (TM) Management of Invasive Fungal Infections: Spectrum of Antifungal Therapies. 
  Mullane KM, University of Medicine of New Jersey and Dentistry; Center for Continuing and Outreach Education and
  12/1/2007
• Efficacy and Safety of Echinocandin Prophylaxis against Invasive Fungal Infection during Stem Cell Transplantation. 
  Mullane KM, University of Medicine of New Jersey and Dentistry Center for Continuing and Outreach Education and
  4/1/2005